Alnylam Pharmaceuticals
ALNY
#622
Rank
C$45.48 B
Marketcap
$352.65
Share price
2.75%
Change (1 day)
46.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of September 2024 : C$46.48 Million

According to Alnylam Pharmaceuticals 's latest financial reports the company has C$46.48 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-C$0.3 Billion36.31%
2022-12-31$-C$0.22 Billion-128.64%
2021-12-31$C$0.74 B-42.15%
2020-12-31$C$1.29 B-31.04%
2019-12-31$C$1.87 B5.95%
2018-12-31$C$1.77 B-20.14%
2017-12-31$C$2.22 B79.59%
2016-12-31$C$1.23 B-29.51%
2015-12-31$C$1.75 B61.47%
2014-12-31$C$1.08 B277.55%
2013-12-31$C$0.28 B115.89%
2012-12-31$C$0.13 B11.06%
2011-12-31$C$0.12 B-24.12%
2010-12-31$C$0.15 B-15.53%
2009-12-31$C$0.18 B-23.81%
2008-12-31$C$0.24 B23.69%
2007-12-31$C$0.19 B-15.17%
2006-12-31$C$0.23 B225.65%
2005-12-31$C$71.92 M29.78%
2004-12-31$C$55.42 M-259.97%
2003-12-31$-C$34.65 Million372.13%
2002-12-31$-C$7.34 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$0.27 B 490.54%๐Ÿ‡บ๐Ÿ‡ธ USA
C$42.13 B 90,540.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.75 B 3,674.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.01 B 4,237.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.12 B 168.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$62.41 B 134,167.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$112.43 B 241,760.67%๐Ÿ‡ซ๐Ÿ‡ท France
C$9.17 B 19,631.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel